A study published in Nature Chemistry by researchers from the University of Pittsburgh and Yale University shows how common ...

Researchers have found that gut bacteria can interfere with the effectiveness of over 400 commonly used medications that ...

Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study ...

Common gut bacteria can metabolise some oral medications potentially rendering these important drugs against migraines, depression, type 2 diabetes, and prostate cancer less ...

Common gut bacteria may interfere with the effectiveness of widely used medications for conditions such as migraines, depression, type 2 diabetes, and prostate cancer, a new study has revealed.

Researchers were able to observe, at atomic scale and in real time, how membrane lipids interact with G protein-coupled receptors (GPCRs) in their natural environment. These interactions reveal ...

American Century Companies Inc. increased its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) ...

STRASBOURG, France, MONTREAL and BOSTON, April 1, 2025 /PRNewswire/ -- Domain Therapeutics ("Domain" or "the Company"), the GPCR experts harnessing deep receptor biology to develop breakthrough ...

Structure Therapeutics Inc.’s GPCR share price has dipped by 12.27%, which has investors questioning if this is right time to buy.

Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) has been given an average rating of “Buy” by the eight research ...

A new study, published today in Nature Chemistry by researchers from the University of Pittsburgh and Yale University, shows ...